BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36605836)

  • 1. Conversion surgery after lenvatinib treatment for multiple lung metastases from hepatocellular carcinoma.
    Sano S; Asahi Y; Kamiyama T; Kakisaka T; Orimo T; Nagatsu A; Aiyama T; Kazui K; Shomura H; Ueki S; Sakamoto Y; Shirakawa C; Kamachi H; Sugino H; Mitsuhashi T; Taketomi A
    Int Cancer Conf J; 2023 Jan; 12(1):7-13. PubMed ID: 36605836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion hepatectomy for advanced hepatocellular carcinoma after right portal vein transection and lenvatinib therapy.
    Ohya Y; Hayashida S; Tsuji A; Kuramoto K; Shibata H; Setoyama H; Hayashi H; Kuriwaki K; Sasaki M; Iizaka M; Nakahara O; Inomata Y
    Surg Case Rep; 2020 Dec; 6(1):318. PubMed ID: 33301055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful hepatic resection for recurrent hepatocellular carcinoma after lenvatinib treatment: A case report.
    Yokoo H; Takahashi H; Hagiwara M; Iwata H; Imai K; Saito Y; Matsuno N; Furukawa H
    World J Hepatol; 2020 Dec; 12(12):1349-1357. PubMed ID: 33442460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Checkpoint Inhibitor-Based Systemic Therapy Shows Remarkable Curative Effect in a Hepatocellular Carcinoma Patient With Intractable Postoperative Recurrence and Metastases: A Case Report and Literature Review.
    He X; Peng Y; Zhou Z; Li W
    Front Oncol; 2022; 12():784224. PubMed ID: 35372050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete pathological response induced by sorafenib for advanced hepatocellular carcinoma with multiple lung metastases and venous tumor thrombosis allowing for curative resection.
    Kitajima T; Hatano E; Mitsunori Y; Taura K; Fujimoto Y; Mizumoto M; Okajima H; Kaido T; Minamiguchi S; Uemoto S
    Clin J Gastroenterol; 2015 Oct; 8(5):300-5. PubMed ID: 26249525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of conversion hepatectomy for huge ruptured hepatocellular carcinoma after transarterial embolization and lenvatinib therapy.
    Naganuma A; Suzuki Y; Hoshino T; Yasuoka H; Tamura Y; Naruse H; Tanaka H; Hirai K; Sakamoto I; Ogawa T; Hatanaka T; Kakizaki S
    Clin J Gastroenterol; 2022 Feb; 15(1):177-184. PubMed ID: 34811701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumothorax during lenvatinib treatment for hepatocellular carcinoma with lung metastasis.
    Kawanishi Y; Kuwahara M; Utsunomiya M; Ishida N; Ishikawa Y; Hiroi M; Akimori T
    Clin J Gastroenterol; 2021 Feb; 14(1):288-292. PubMed ID: 33108567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robot Assisted Laparoscopy Combined with Thoracoscopy in the Treatment of Hepatocellular Carcinoma with Inferior Vena Cava Tumor Thrombus.
    Song C; Chen M; Zhu Z; Chen J; Jin R; Zhang Y; Gong L; Yang Z; Liang X
    Ann Surg Oncol; 2023 Sep; 30(9):5447-5449. PubMed ID: 37285097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-programmed cell death ligand 1-based immunotherapy in recurrent hepatocellular carcinoma with inferior vena cava tumor thrombus and metastasis: Three case reports.
    Liu SR; Yan Q; Lin HM; Shi GZ; Cao Y; Zeng H; Liu C; Zhang R
    World J Clin Cases; 2021 Jul; 9(21):5988-5998. PubMed ID: 34368318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion Hepatectomy for Huge Hepatocellular Carcinoma With Arterioportal Shunt After Chemoembolization and Lenvatinib Therapy.
    Sato N; Beppu T; Kinoshita K; Yuki H; Suyama K; Chiyonaga S; Motohara T; Komohara Y; Hara A; Akahoshi S
    Anticancer Res; 2019 Oct; 39(10):5695-5701. PubMed ID: 31570469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual Techniques for Preserving Surgical and Oncologic Safety in Hepatectomy of Advanced Adrenal Malignancy with Vena Cava and Liver Invasion.
    Lee JM; Lee KW; Hong SK; Yoon KC; Cho JH; Yi NJ; Suh KS
    Ann Surg Oncol; 2018 Oct; 25(11):3324-3325. PubMed ID: 30019302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion therapy for unresectable hepatocellular carcinoma after lenvatinib: Three case reports.
    Tomonari T; Sato Y; Tanaka H; Tanaka T; Taniguchi T; Sogabe M; Okamoto K; Miyamoto H; Muguruma N; Saito Y; Imura S; Bando Y; Shimada M; Takayama T
    Medicine (Baltimore); 2020 Oct; 99(42):e22782. PubMed ID: 33080748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rechallenge with Lenvatinib after Refractoriness to Initial Lenvatinib Followed by Sorafenib in a Patient with Metastatic Papillary Thyroid Carcinoma.
    Takinami M; Yokota T
    Case Rep Oncol; 2020; 13(2):522-527. PubMed ID: 32518548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion surgery after preoperative therapy for advanced hepatocellular carcinoma in the era of molecular targeted therapy and immune checkpoint inhibitors.
    Arita J; Ichida A; Nagata R; Mihara Y; Kawaguchi Y; Ishizawa T; Akamatsu N; Kaneko J; Hasegawa K
    J Hepatobiliary Pancreat Sci; 2022 Jul; 29(7):732-740. PubMed ID: 35306748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion surgery for advanced hepatocellular carcinoma after combination treatment of lenvatinib and camrelizumab: a case report.
    Chen Z; Chen Z; Fan W; Zou Y; Zhang Y; Shi N; Jin H
    World J Surg Oncol; 2023 Jan; 21(1):29. PubMed ID: 36721173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downstaging of Recurrent Advanced Hepatocellular Carcinoma After Lenvatinib Treatment: Opportunities or Pitfalls? A Case Report.
    Liu Z; Fu Z; Li G; Lin D
    Onco Targets Ther; 2020; 13():10267-10273. PubMed ID: 33116607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma.
    Zhu XD; Huang C; Shen YH; Xu B; Ge NL; Ji Y; Qu XD; Chen L; Chen Y; Li ML; Zhu JJ; Tang ZY; Zhou J; Fan J; Sun HC
    Ann Surg Oncol; 2023 May; 30(5):2782-2790. PubMed ID: 36178565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion hepatectomy for hepatocellular carcinoma with main portal vein tumour thrombus after lenvatinib treatment: A case report.
    Takahashi K; Kim J; Takahashi A; Hashimoto S; Doi M; Furuya K; Hashimoto R; Owada Y; Ogawa K; Ohara Y; Akashi Y; Hisakura K; Enomoto T; Shimomura O; Noguchi M; Oda T
    World J Hepatol; 2021 Mar; 13(3):384-392. PubMed ID: 33815680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggressive surgical resection for hepatocellular carcinoma with tumor thrombus extending to inferior vena cava and synchronous pulmonary metastasis.
    Kitayama D; Yoshidome H; Mitsuhashi N; Ito H; Kimura F; Shimizu H; Ohtsuka M; Miyazaki M
    Hepatogastroenterology; 2004; 51(59):1326-9. PubMed ID: 15362744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report: Conversion therapy to permit resection of initially unresectable hepatocellular carcinoma.
    Chen K; Luo CP; Ge DX; Wang KL; Luo Q; Li YZ; You XM; Xiang BD; Li LQ; Ma L; Zhong JH
    Front Oncol; 2022; 12():946693. PubMed ID: 36276151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.